Acasti Pharma (NASDAQ:ACST – Get Free Report) announced its quarterly earnings results on Friday. The biopharmaceutical company reported ($0.18) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.48) by $0.30, Yahoo Finance reports.
Acasti Pharma Stock Down 1.8 %
NASDAQ ACST opened at $3.24 on Monday. The company has a market capitalization of $30.46 million, a price-to-earnings ratio of -0.65 and a beta of 1.61. Acasti Pharma has a twelve month low of $1.72 and a twelve month high of $3.84. The stock has a fifty day simple moving average of $2.94 and a 200 day simple moving average of $2.91.
Acasti Pharma Company Profile
See Also
- Five stocks we like better than Acasti Pharma
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Risk Tolerance vs Risk Capacity: Key Differences & How to Measure
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Ciena Stock: Powering the AI Boom – A Network Infrastructure Play
- 3 REITs to Buy and Hold for the Long Term
- Is NVIDIA Stock Done Playing With the Market? Buy, Sell, or Hold
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.